Myo-Inositol: Clinical Evidence & Substantiation Summary
What Is Myo-Inositol?
Myo-inositol is a naturally occurring sugar alcohol that acts as a second messenger in intracellular signaling, particularly for insulin and follicle-stimulating hormone (FSH). It is one of the most studied supplements for metabolic and reproductive health.
Mechanism of action: Inositol-based signaling molecules (IP3, PIP3) mediate the cellular response to insulin, promoting glucose uptake and glycogen synthesis. In the ovaries, myo-inositol increases insulin sensitivity and regulates FSH signaling, supporting healthy ovulation.
Clinical Evidence Summary
Below are 3 key clinical studies on Myo-Inositol. Nutra Comp analyses 118+ studies in its full clinical evidence report.
Myo-inositol and D-chiro-inositol for PCOS: meta-analysis
Population: 10 RCTs
Key finding: Inositol supplementation significantly improved ovulation rates, reduced androgen levels, and improved metabolic parameters in women with PCOS (p<0.001).
Myo-inositol for metabolic syndrome: meta-analysis
Population: 14 RCTs
Key finding: Myo-inositol supplementation significantly reduced hba1c, fasting glucose, and blood pressure (p<0.01) across diverse populations.
Myo-inositol and anxiety: systematic review
Population: 7 studies
Key finding: High-dose myo-inositol (12–18 g/day) showed therapeutic efficacy for panic disorder and OCD comparable to some SSRIs, with fewer side effects.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Myo-Inositol
Includes all 118+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is inositol FDA approved?
Inositol is classified as a dietary supplement and has GRAS status. It does not have an RDA and is not FDA approved as a drug.
What is the difference between Myo and D-Chiro?
Myo-inositol is a general signaling molecule; D-chiro-inositol is specifically involved in glycogen synthesis. The body maintains a 40:1 ratio (Myo:D-chiro), which is the ratio often used in clinical studies.
Can it help with cravings?
By improving insulin sensitivity and stabilizing blood sugar signaling, many users and clinicians report reduced sugar cravings and better appetite control.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist